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ABSTRACT
Objective: Increasing of adipose tissue in obesity make an inflammation cellular due to stress oxidative. Malondialdehyde (MDA) is produced by that 
cellular reaction and used as indicator peroxidation lipid reaction in many tissues. Vitamin E will inhibit lipid peroxidation reaction. This study is 
about the effectiveness of vitamin E to decrease the MDA level in obesity women.
Methods: The pre- and post-test control group design study was conducted on 24 female obese women. Subjects were divided into two groups 
randomly with 12 women each group. Control group was given placebo capsules, and the experimental group was given vitamin E capsules 400 IU for 
30 days. MDA level was measured before and after treatment, analyzed by independent t-test and the p<0.05 was considered significant.
Results: The decreasing of MDA level of the control group was 1.601±0.313 µmol/ml, and experimental group was 2.161±0.471 µmol/ml. From 
post-test result comparison, the experimental group shows a significant decrease (p<0.05) of MDA level.
Conclusion: Vitamin E supplementation can decrease MDA level in obese women staff at School of Medicine Udayana University.
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INTRODUCTION
Obesity is complex and the chronological disease that affects millions 
of people worldwide and contributes substantial morbidity and 
mortality [1]. Obesity has become a major health problem worldwide, 
affecting people across all ages, sex, ethnicities, and races. Prevalence 
of obesity was higher in urban than rural people with significant 
increases in obesity rates among women [2]. In an urban area, most 
women work in sedentary activity such as office staff that will increase 
obese risk. Obesity is not just a condition with the amount of excess 
fat deposit, but also about the distribution of fat throughout the body. 
The distribution of fat may increase the risk of obesity that associated 
with various degenerative diseases [3]. Excess fat in adipose tissue 
will increase oxidation process. Oxidation in adipose tissue inhibits 
cell oxygenation that leads to molecular inflammation in the tissue, 
which activating macrophages and vascular endothelial cells leading 
to cellular inflammation [4]. Increasing the amount of fat will increase 
the oxidation process, which leads to oxygen dysfunction and resulting 
more inflammation. Inflammation is a source of oxidative stress.
Oxidative stress is a condition in which an increase in reactive 
oxygen species (ROS) will cause cell, tissue or organ damage. High 
concentration of ROS and free radicals damage deoxyribonucleic acid, 
proteins, carbohydrates and lipid constituent, and compromise cell 
function [2,5]. Under conditions of oxidative stress, free radicals will 
cause cell membrane lipid peroxidation and damage the organization 
of cell membranes. This cell membrane is essential for the function 
of the receptor and the function of the enzyme. Peroxidations of lipid 
cell membranes by free radicals can loss of cellular function. Lipid 
peroxidation is a mechanism of cellular trauma, both in plants and 
animals, thus lipid peroxidation is used as an indicator of oxidative 
stress in cells and tissues [6].
One of the compounds that produced by lipid peroxide reaction is 
malondialdehyde (MDA). MDA is formed by the degradation of hydroxyl 
(OH) free radicals to unsaturated fatty acids, which are later transported 
into highly reactive free radical. Therefore, MDA measurement is often 
used as an indicator of tissue lipid peroxidation [6]. Increased oxidative 
stress will increase MDA levels. Oxidative stress in the body can be 
suppressed by antioxidant. Antioxidant is a substance that can neutralize 
free radicals and prevents harmful effect to the body’s biological system 
from excessive oxidation reactions [7]. It was suggested, antioxidant as 
a neutralizing agent of free radicals has known as enzymes, and some 
are micronutrients. Antioxidant enzymes which are formed in the body 
such as superoxide dismutase, glutathione peroxidase, catalase, and 
glutathione reductase. Meanwhile, antioxidant from micronutrients 
has known as three major kinds such as beta-carotene, vitamin C, and 
vitamin E [8]. Beta-carotene is single oxygen scavengers, vitamin C 
is superoxide scavengers and other free radicals, and vitamin E is 
a fat peroxide chain breaker in cell membranes. Vitamin E is found 
in lipoproteins, cell membranes and extracellular fluids. Fat-soluble 
vitamin E is an antioxidant that protects polyunsaturated fatty acids and 
cell components and cell membranes from oxidation by free radicals. It 
controls the fat peroxide by donating hydrogen into the reaction, and 
block additionally peroxide activities thus breaking the chain reaction 
and limiting the damage [9].
Based on the antioxidant ability of vitamin E, the authors are interested 
to know the effects of vitamin E in reducing oxidative stress of obese 
women staff.
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Table 1: Patients characteristics data
Variable Group p
Placebo Vitamin E
Age (years) 40.91±6.38 39.67±6.53 0.650
Weight (kg) 68.36±4.27 72.25±9.14 0.152
Height (cm) 154.36±6.98 157.50±3.37 0.178
BMI (kg/m2) 27.22±1.79 29.04±3.30 0.062
n=12 each group. BMI: Body mass index
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METHODS
The study was conducted in the Department of Physiology, School of 
Medicine, Udayana University take place during June to September 
2016. Subjects were enrolled from all women staff at School of 
Medicine Udayana University who suffered from obesity after taking 
ethical clearance from Ethics Committee of the School of Medicine, 
Udayana University. The inclusion criteria of the population study are 
informed consent, obese woman (body mass index [BMI] >25 kg/m2), 
age 25-45 years and no pathological history or chronic disease. Women 
with history taking any medication known to influence metabolic and 
immune system, vitamin supplement and another antioxidant 1 week 
before research, vegetarian, and follow training program were excluded. 
Drop out categorized if the subject could not complete the vitamin E 
treatment. The sample size is determined by the Pocock formula. Based 
on the previous study, the sample size was calculated with alpha error 
of 0.5 and power of 80%. A sample size power calculation determined 
that 12 patients were needed in each group. Total 24 women were 
selected. They were placed into two groups (experimental and control 
group) with simple random sampling. All of them had joined the study 
involuntarily based and given informed consent.
The experimental group received vitamin E capsules 400 IU once 
daily. The control group received a placebo drug. Patients came every 
day and nurse registered patients and delivered the drugs to the 
patients. The venous blood sample was collected twice, before and after 
treatment. Level of MDA in blood was measured with enzyme-linked 
immunosorbent assay standard kit, and the results were compared 
between the groups. The data obtained were statistically analyzed by 
independent t-test and the p<0.05 was considered significant.
RESULTS
Data were summarized as mean±standard deviation. Groups were 
compared by independent Student’s t-test. A two-sided (α=2) p<0.05 
was considered statistically significant. All analysis was performed on 
SPSS (version 17.0) software.
The study evaluates the effect of oral administration of vitamin E 400 IU 
on MDA level of obese women. There was no statistically significant 
difference in basic parameter among subjects of two groups (Table 1). 
In other words, subjects of two groups were matched and comparable.
After 1 month of vitamin E supplementation, the mean level of MDA was 
found lower in vitamin E group. Mean changes of MDA level before and 
after treatment higher in group vitamin E compared to group placebo 
significantly (p=0.003) (Table 2).
DISCUSSION
There are several possible contributors to oxidative stress in obesity 
including hyperglycemia, increased muscle activity to carry excessive 
weight, elevated tissue lipid levels, chronic inflammation, endothelial 
ROS production, hyperleptinemia, and inadequate antioxidant 
defenses [9]. These factors are not mutually exclusive, obesity may 
involve some or all of these contribute to systemic oxidative stress. 
Inadequacy of antioxidant defenses may begin with a low intake of 
protective antioxidants and phytochemicals in diet [10]. In previous 
research was found a significant reduction in antioxidant enzymes 
activity and glutathione level in almost all tissue of high-fat feeding 
mice compared with non-fat animals. On the other hand, non-enzymatic 
oxidative stress parameters lipid peroxidation markers MDA and 
protein oxidation markers level increased in these tissues. Increased 
MDA levels by the effects of high-fat diet were normalized in all tissues 
except the kidney with vitamin E [11]. This is in accordance with our 
results that vitamin E can decrease MDA levels in obese woman staff.
All the subjects in this study had BMI >25 kg/m2, based on obese criteria 
of Asia Pacific BMI category. In the previous study, serum levels of dietary 
antioxidants (beta-carotene, vitamin E and C) were found to be lower in 
obese than non-obese and supplementation of vitamin E will help to 
maintain the lack of vitamin and antioxidants in obesity and may be 
effective in suppressing multiple oxidative pathways to obesity-induced 
disease [12]. Vitamin E (α-tocopherol) a natural antioxidant is known 
to be used to treat and prevent the diseases [13]. Supplementation 
of vitamin E in this study is also supported by the previous research 
about antioxidant levels in obese women. This research showed that 
vitamin E levels in obese women (0.70±0.10 mg/dl) are lower than 
healthy women (0.87±0.16 mg/dl), p<0.05. It means that obese women 
need vitamin E supplementation [14].
In this study, after 1 month supplementation, mean change in MDA 
level was higher in group vitamin E than group placebo. Vitamin E is 
controlling the lipid peroxide by donating hydrogen into the reaction, 
blocks the additional activity performed by peroxides, thus breaking 
the chain reaction and limiting the damage. That reaction will decrease 
MDA level as a product from lipid peroxide reaction [6].
Other research also support that vitamin E supplementation in 
human subjects and animal models has been shown to decrease lipid 
peroxidation, superoxide (O2−) production by impairing the assembly 
of nicotinamide adenine dinucleotide phosphate (reduced form) 
oxidase as well as by decreasing the expression of scavenger receptors 
(SR-A and CD36), particularly important in the formation of foam 
cells [15]. Vitamin E action over peroxidation was able to enhance the 
antioxidant defense of both glutathione-related enzymes. These data 
support that antioxidant supplementation produces a protective effect 
on the oxidative damage induced by obesity [16].
CONCLUSION
Supplementation of vitamin E 400 IU for 30 days can decrease MDA 
level in obese women staff School of Medicine Udayana University. It 
will support the usage of vitamin E as a supportive treatment to reduce 
oxidative stress in obesity. However, to achieve more confirmatory 
results further study on larger sample size is needed.
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